These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 17893004

  • 1. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease.
    Hajer GR, van der Graaf Y, Olijhoek JK, Edlinger M, Visseren FL.
    Am Heart J; 2007 Oct; 154(4):750.e1-7. PubMed ID: 17893004
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.
    Hjortnaes J, Algra A, Olijhoek J, Huisman M, Jacobs J, van der Graaf Y, Visseren F.
    J Rheumatol; 2007 Sep; 34(9):1882-7. PubMed ID: 17696269
    [Abstract] [Full Text] [Related]

  • 6. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS, Park JS, Cho MH, Jee SH, Lee HS, Ahn CW, Lowe WL, Kim KR.
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [Abstract] [Full Text] [Related]

  • 7. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin.
    Nishida H, Horio T, Suzuki Y, Iwashima Y, Kamide K, Kangawa K, Kawano Y.
    Peptides; 2008 Apr; 29(4):599-605. PubMed ID: 18222566
    [Abstract] [Full Text] [Related]

  • 8. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL, van der Graaf Y, Spiering W, Visseren FL, SMART study group.
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [Abstract] [Full Text] [Related]

  • 9. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
    Tsao YT, Hsu YJ, Chu NF, Lai CH, Chiu JS, Lin SH.
    J Nephrol; 2008 May; 21(5):744-52. PubMed ID: 18949730
    [Abstract] [Full Text] [Related]

  • 10. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Wassink AM, van der Graaf Y, Olijhoek JK, Visseren FL, SMART Study Group.
    Eur Heart J; 2008 Jan; 29(2):213-23. PubMed ID: 18199567
    [Abstract] [Full Text] [Related]

  • 11. Adiponectin and insulin sensitivity in primary aldosteronism.
    Fallo F, Della Mea P, Sonino N, Bertello C, Ermani M, Vettor R, Veglio F, Mulatero P.
    Am J Hypertens; 2007 Aug; 20(8):855-61. PubMed ID: 17679033
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K, Aso Y, Mittermayer F, Inukai T, Brix J, Schernthaner G.
    Transl Res; 2009 Apr; 153(4):199-203. PubMed ID: 19304279
    [Abstract] [Full Text] [Related]

  • 15. Circulating adiponectin: associations with risk factors and the Reynolds risk score in women without prior major cardiovascular events.
    Calomfirescu N, Popa C, Jurcut R, Serban M, Ginghina C.
    Cardiology; 2010 Apr; 115(1):64-70. PubMed ID: 19864901
    [Abstract] [Full Text] [Related]

  • 16. Plasma adiponectin in heart transplant recipients.
    Ambrosi P, Oddoze C, Nicolay A, Penet-Lorec AM, Riberi A, Métras D, Portugal H, Habib G.
    Clin Transplant; 2009 Apr; 23(1):83-8. PubMed ID: 19200219
    [Abstract] [Full Text] [Related]

  • 17. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A, Hergenç G, Can G, Küçükdurmaz Z.
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [Abstract] [Full Text] [Related]

  • 18. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [Abstract] [Full Text] [Related]

  • 19. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
    Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, Inukai T, Okuno T, Node K.
    Am J Cardiol; 2007 Aug 15; 100(4):569-74. PubMed ID: 17697807
    [Abstract] [Full Text] [Related]

  • 20. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.
    Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH.
    Am J Cardiol; 2009 May 15; 103(10):1411-6. PubMed ID: 19427438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.